482 related articles for article (PubMed ID: 32419528)
1. Aloin suppresses lipopolysaccharide-induced acute lung injury by inhibiting NLRP3/NF-κB via activation of SIRT1 in mice.
Lei J; Shen Y; Xv G; Di Z; Li Y; Li G
Immunopharmacol Immunotoxicol; 2020 Aug; 42(4):306-313. PubMed ID: 32419528
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages.
Zhou Y; Zhang CY; Duan JX; Li Q; Yang HH; Sun CC; Zhang J; Luo XQ; Liu SK
Biomed Pharmacother; 2020 Jan; 121():109596. PubMed ID: 31731193
[TBL] [Abstract][Full Text] [Related]
3. Suppression of NLRP3 and NF-κB signaling pathways by α-Cyperone via activating SIRT1 contributes to attenuation of LPS-induced acute lung injury in mice.
Liu X; Jin X; Yu D; Liu G
Int Immunopharmacol; 2019 Nov; 76():105886. PubMed ID: 31520990
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation.
Jiang L; Zhang L; Kang K; Fei D; Gong R; Cao Y; Pan S; Zhao M; Zhao M
Biomed Pharmacother; 2016 Dec; 84():130-138. PubMed ID: 27643555
[TBL] [Abstract][Full Text] [Related]
5. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway.
Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z
J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012
[TBL] [Abstract][Full Text] [Related]
6. Suppression of NLRP3 inflammasome by Platycodin D via the TLR4/MyD88/NF-κB pathway contributes to attenuation of lipopolysaccharide induced acute lung injury in rats.
Wu Y; Huang D; Wang X; Pei C; Xiao W; Wang F; Wang Z
Int Immunopharmacol; 2021 Jul; 96():107621. PubMed ID: 33872850
[TBL] [Abstract][Full Text] [Related]
7. Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-κB Pathway and NLRP3 Inflammasome Activation.
Zhang H; Chen S; Zeng M; Lin D; Wang Y; Wen X; Xu C; Yang L; Fan X; Gong Y; Zhang H; Kong X
Cell Physiol Biochem; 2018; 49(5):1918-1932. PubMed ID: 30235451
[TBL] [Abstract][Full Text] [Related]
8. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury
Han S; Yuan R; Cui Y; He J; Wang QQ; Zhuo Y; Yang S; Gao H
Front Immunol; 2022; 13():846384. PubMed ID: 35281058
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of pteryxin on LPS-induced acute lung injury via modulating MAPK/NF-κB pathway and NLRP3 inflammasome activation.
Xuan TQ; Gong G; Du H; Liu C; Wu Y; Bao G; Ma Q; Zhen D
J Ethnopharmacol; 2022 Mar; 286():114924. PubMed ID: 34942323
[TBL] [Abstract][Full Text] [Related]
10. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroids alleviate lipopolysaccharide-induced inflammation and lung injury via inhibiting NLRP3-inflammasome activation.
Yang JW; Mao B; Tao RJ; Fan LC; Lu HW; Ge BX; Xu JF
J Cell Mol Med; 2020 Nov; 24(21):12716-12725. PubMed ID: 32977368
[TBL] [Abstract][Full Text] [Related]
12. Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways.
Yang H; Lv H; Li H; Ci X; Peng L
Cell Commun Signal; 2019 Jun; 17(1):62. PubMed ID: 31186013
[TBL] [Abstract][Full Text] [Related]
13. Fraxin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting the NF-κB and NLRP3 signalling pathways.
Li W; Li W; Zang L; Liu F; Yao Q; Zhao J; Zhi W; Niu X
Int Immunopharmacol; 2019 Feb; 67():1-12. PubMed ID: 30530164
[TBL] [Abstract][Full Text] [Related]
14. Garlic oil supplementation blocks inflammatory pyroptosis-related acute lung injury by suppressing the NF-κB/NLRP3 signaling pathway via H
Dilxat T; Shi Q; Chen X; Liu X
Aging (Albany NY); 2024 Apr; 16(7):6521-6536. PubMed ID: 38613798
[TBL] [Abstract][Full Text] [Related]
15. Genipin alleviates LPS-induced acute lung injury by inhibiting NF-κB and NLRP3 signaling pathways.
Zhang A; Wang S; Zhang J; Wu H
Int Immunopharmacol; 2016 Sep; 38():115-9. PubMed ID: 27262946
[TBL] [Abstract][Full Text] [Related]
16. Saikosaponin a Ameliorates LPS-Induced Acute Lung Injury in Mice.
Du ZA; Sun MN; Hu ZS
Inflammation; 2018 Feb; 41(1):193-198. PubMed ID: 28986747
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
Yang S; Yu Z; Yuan T; Wang L; Wang X; Yang H; Sun L; Wang Y; Du G
Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503
[TBL] [Abstract][Full Text] [Related]
18. Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injury.
Zhang Q; Yang C; Ma S; Guo S; Hu X; Zhou Z; Liu Y; Zhang X; Jiang R; Zhang Z; Wen L
J Ethnopharmacol; 2023 Sep; 313():116615. PubMed ID: 37164255
[TBL] [Abstract][Full Text] [Related]
19. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
Dong L; Zhu YH; Liu DX; Li J; Zhao PC; Zhong YP; Chen YQ; Xu W; Zhu ZQ
J Immunol Res; 2019; 2019():7264383. PubMed ID: 30937316
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of curcumin in acute lung injury: In vivo and in vitro experimental model studies.
Wang Y; Wang Y; Cai N; Xu T; He F
Int Immunopharmacol; 2021 Jul; 96():107600. PubMed ID: 33798807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
